What do systematic reviews say?

Calcium channel blockers vs placebo/no treatment

Calcium channel blockers showed no clear difference in death compared with placebo/no treatment (low certainty).

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  RR 0.82 [0.37, 1.82]
  12 studies · 792 participants
  Low

Calcium channel blockers vs placebo/no treatment

Calcium channel blockers may leads to lower graft loss compared with placebo/no treatment (low certainty).

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  RR 0.75 [0.57, 0.99]
  17 studies · 1255 participants
  Low

Calcium channel blockers vs placebo/no treatment

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  no estimate extracted
  18 studies · 1119 participants
  Moderate

Calcium channel blockers vs placebo/no treatment

Calcium channel blockers showed no clear difference in acute rejection compared with placebo/no treatment (low certainty).

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  RR 1.02 [0.85, 1.23]
  11 studies · 771 participants
  Low

Calcium channel blockers vs placebo/no treatment

Calcium channel blockers showed no clear difference in withdrawal due to side effects compared with placebo/no treatment (low certainty).

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  RR 0.99 [0.53, 1.87]
  2 studies · 156 participants
  Low

Calcium channel blockers vs placebo/no treatment

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 90 participants
  Low

Calcium channel blockers vs placebo/no treatment

• Antihypertensive treatment for kidney transplant recipients 2009 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 590 participants
  Very low

Dihydropyridine calcium channel blockers vs placebo or control

• Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 39 participants
  Low

Dihydropyridine calcium channel blockers vs placebo or control

• Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 76 participants
  Low

Dihydropyridine calcium channel blockers vs placebo or control

• Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 124 participants
  GRADE not reported

Dihydropyridine calcium channel blockers vs placebo or control

Dihydropyridine calcium channel blockers showed no clear difference in intradialytic hypotension compared with placebo/control (low certainty).

• Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
  RR 0.54 [0.25, 1.15]
  2 studies · 287 participants
  Low

Dihydropyridine calcium channel blockers vs placebo or control

The review found no eligible studies for this question.

• Calcium channel blockers for people with chronic kidney disease requiring dialysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found